NCT00193648View on ClinicalTrials.gov

Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

October 31, 2007

Conditions
Focal Glomerulosclerosis
Interventions
DRUG

Rosiglitazone (Avandia)

oral drug administration

DRUG

Adalimumab (Humira)

Injection of drug biweekly

Trial Locations (2)

11040

Howard Trachtman, New Hyde Park

27599-7155

Debbie Gipson, Chapel Hill

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
collaborator

University of North Carolina

OTHER

collaborator

The Cleveland Clinic

OTHER

lead

Northwell Health

OTHER

NCT00193648 - Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) | Biotech Hunter | Biotech Hunter